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& Abstract
Objective: To evaluate the results of lumbar epiduroscopic
adhesiolysis using mechanical methods and a radiofrequency
catheter followed by epidural steroid and local anesthetic
administration in patients with postoperative fibrosis and
persistent or recurrent symptoms.
Study Design: Prospective study.
Methods: Patients with persistent or recurrent low back
and/or lower limb pain after lumbar spine surgery, in whom
no relevant findings were present on MR images besides
epidural scar tissue, were submitted to epiduroscopic adhes-
iolysis. Patient-reported outcomes including pain and dis-
ability were assessed in predefined time intervals and
compared to baseline.
Results: Twenty-four patients were enrolled. It was possible
to elicit the patient’s usual pain by probing the epidural scar
tissue in all patients. Statistically significant improvement in
low back and lower limb pain was observed in all assessment
periods up to 12 months. A pain relief over 50%was achieved
in 71% of the patients at 1 month, 63% at 3 and 6 months,
and 38% at 12 months. Disability scores significantly
improved for around 6 months. Mean patient satisfaction
rates were 80% at 1 month, 75% at 3 months, 70% at
6 months, and 67% 1 year after intervention. Only 1 tran-
sient postprocedural complication was detected.
Conclusion: Endoscopic adhesiolysis is a potentially useful
treatment for the relief of chronic intractable low back and
lower limb pain in patients with previous lumbar spine
surgery and epidural fibrosis. The use of larger volumes of
saline during endoscopy and the employment of radiofre-
quency for the lysis of epidural adhesions are safe proce-
dures, which may provide an additional benefit to the
intervention. &
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INTRODUCTION
Persistence or recurrence of pain after lumbar spine
surgery is not rare.1–4 In both cases, there are patients in
whom, even after an exhaustive and detailed investiga-
tion, the cause for the symptoms is not obvious.1,2,4
Epidural fibrosis is mentioned in the literature as a
common cause of pain after lumbar spine surgery and
has been implicated in 8% to over 60% of cases of
“failed back surgery syndrome” (FBSS),3–7 despite
several studies refuting any association.8–12 Moreover,
recent literature suggests that magnetic resonance imag-
ing (MRI) may not be the most sensitive method for the
diagnosis of epidural fibrosis. Using epiduroscopy as a
diagnostic method, Bosscher and Heavner report severe
fibrosis in 83% of their patients with persistent or
recurrent symptoms after lumbar surgery.13 Richardson
et al.14 found adhesions in all patients in their series.
These incidences are about 5 times higher than those
found in studies using MR imaging with contrast
enhancement.4
In epidural fibrosis, fibrous scar tissue replaces the
epidural fat and, unlike the latter, can cause compres-
sion, adherence, and tethering of the dura mater and
nerve roots to the surrounding structures.4,15–18 Epidu-
ral fibrosis can also impair the perineural microcircula-
tion19 and nutrition of the nerve root through the
cerebrospinal fluid,20 induce intraneural edema and
focal demyelination,21 and release pro-inflammatory
cytokines which may trigger pain responses from the
dorsal root ganglion.22
A surgical reintervention in cases of epidural fibrosis
entails a higher risk of complications, particularly
dural tears and arachnoiditis.23–25 In addition, the
long-term success rate after a repeated operation has
been reported to be as low as about 30% and appears
to be lower in cases where epidural fibrosis is more
substantial.3,26–28
Epidural fibrosis has been addressed for a long time
by epidural steroid injections and percutaneous and
endoscopic adhesiolysis. Systematic assessments of the
benefit of these techniques have been recently pub-
lished.29–31 The success rates of epidural steroid injec-
tions in managing this situation has been reported to be
59% and 58% at 1 and 2 years, considering an average
of 4 and 6 procedures during this period.32 However, the
average time of pain relief after the procedure was only
about 6 weeks for the first 2 procedures and 13 weeks
for any subsequent procedures.
Another publication from the same group of inves-
tigators, comparing the effectiveness of caudal epidural
injections with percutaneous adhesiolysis, reported
that the average pain relief after adhesiolysis was
12 weeks and 82% of the patients had a significant
improvement in pain and function after 2 years, with
an average number of 6 procedures during the
period.33
The evidence for the effectiveness of epiduroscopic
adhesiolysis in the treatment of “failed back surgery
syndrome” has been considered fair in a recent system-
atic review.31 Another contemporary review made a
positive recommendation for epiduroscopy in patients
with chronic lumbosacral radicular pain refractory to
conservative or minimally invasive therapies.21 Differ-
ent techniques have been used for adhesiolysis during
epiduroscopy, namely mechanical,14,34–38 laser,39–43
radiofrequency,18,44,45 and chemical.46 Most often,
steroids and local anesthetics are injected in the epidural
space after adhesiolysis,14,34,35,47,48 but other sub-
stances have been used, namely clonidine,14,46 hyal-
uronidase,38,46 ciprofloxacin,38 and ozone.36,38
The purpose of this study is to evaluate the
effectiveness of lumbar epiduroscopic adhesiolysis
using mechanical methods, mostly combined with a
radiofrequency catheter, followed by epidural admin-
istration of a steroid and a local anesthetic in a group
of patients with postoperative fibrosis and persistent
or recurrent painful symptoms after lumbar spine
surgery.
METHODS
This study was conducted at a University Hospital. All
patients were recruited from the outpatient spine clinic
of the Neurosurgery Department. The Ethics Committee
approved the study protocol and every patient included
signed a voluntary, written informed consent. Detailed
explanation of the study and the procedure was trans-
mitted orally to every patient by 1 of the co-investigators
(PAS, PM) supplemented by written information and all
patients were given a period of reflection before deciding
to participate in the study.
All patients fulfilling the approved criteria and willing
to participate in the study were consecutively included
from July 2010 through October 2012.
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Participants
Enrollment in the study was restricted to patients over
18 years old, with persistent or recurrent low back and/
or lower limb pain after lumbar discectomy and a VAS
(visual analogue scale) pain score49 of 5/10 or higher.
Symptomatology must have been present for a minimum
of 6 months and has been unresponsive to conservative
management including, at least, medication and a
rehabilitation program. All patients had an MRI scan
and dynamic X-rays of the lumbar spine excluding
recurrent disk herniation, spinal stenosis, spondylolis-
thesis, infection, or any other specific diagnosis as the
cause for the symptoms. In all of them, MRI yielded
contrast-enhancing epidural soft tissue consistent with
fibrous granulation tissue adjacent to the dura mater
and/or nerve root sheet. Patients with facet or sacroiliac
joint pain, as assessed by medial branch blocks or
sacroiliac intra-articular anesthetic injections, were also
excluded from the study.
Exclusion criteria included intracranial hypertension,
coagulopathy, ocular hypertension, retinopathy, renal
failure, cerebrovascular disease, pregnancy and lacta-
tion, sepsis, infection in the region of sacral hiatus,
major psychiatric disturbance, cauda equina syndrome,
congenital or acquired disturbances of the sacral anat-
omy that could interfere with the progression of the
endoscope, and a past history of allergic reactions to
contrast dye, local anesthetics, or steroids.
Screening Evaluation
Screening evaluation included demographic data, work-
ing status, past medical and surgical history, spine
surgery procedure and outcome, pain characteristics and
duration, current medication, spine imaging studies and
ancillary investigations, physical and neurological
examination, VAS pain score49 (back and lower limb),
Portuguese version of the Oswestry Disability Index 2.0
(ODI),50–52 Portuguese version of the Medical Out-
comes Study Short-Form 36 Health Survey (SF-36),53–56
and psychological screening by the Distress and Risk
Assessment Method (DRAM).57–59 All preoperative
scores refer to the condition of the patient on the day
before the intervention.
Epiduroscopy
All patients underwent epiduroscopy under local anes-
thesia and mild sedation (midazolam), performed by a
single surgeon (PP) in a sterile operating room, with the
presence of an anesthesiologist. Prophylactic antibiotic
therapy with cefazolin 1 g IV was given. Pulse oximetry,
ECG, and noninvasive blood pressure monitoring were
used. Procedural data and findings were recorded.
Patients were positioned prone on a radiolucent
operating table, with a soft pillow under the abdomen
to reduce lumbar lordosis. After skin preparation and
sterile adhesive draping, local anesthesia of the region of
the sacral hiatus was performed with lidocaine 2%.
Access to the epidural space through the sacral hiatus
was obtained using an 18-G Tuohy needle under
fluoroscopic guidance and confirmed by injection of
nonionic contrast (Ultravist 240, Bayer Schering
Pharma A.G., Berlin-Wedding, Germany). A short
length of a flexible guidewire was then inserted through
the needle into the sacral canal, and a dilator surrounded
by a plastic sleeve was passed over the guidewire.
After removal of both the guidewire and the dilator, a
flexible, steerable, sterile epiduroscope (Resascope,
MRT – Medical Device Manufacturer s.r.l., San Pietro
Viminario, Padua, Italy) was introduced into the sleeve
and slowly advanced in the epidural space using small
boluses of physiological saline solution to distend and
allow visualization of the epidural space. The volume of
saline solution used for irrigation was monitored but not
limited by protocol. The Resascope is a disposable
device including a 30-cm-long catheter with 3.3 mm
external diameter, whose tip can be moved in 4
directions. The catheter has 2 internal operating chan-
nels with a diameter of 1.25 mm and 4 portals (1 for
irrigation, 1 for passing a flexible 10,000 pixels optics
and 2 for working tools).
When epidural adhesions or scar tissue were identi-
fied, an epidurogram was performed to document filling
defects. Then, the tip of a 3 French (F) Fogarty catheter
(Edwards Lifesciences Corporation, Irvine, CA, U.S.A.)
was used to probe the epidural structures, looking for
eliciting pain concordant with the patient’s usual 1
(epidural pain provocation test).60
Adhesiolysis was performed combining different tech-
niques in each patient, depending on the consistency of
the fibrous tissue. Mild adhesions were overcome by
distention of the epidural space by flushing small boluses
of saline solution and by mechanical dissection with the
tip of a 3F Fogarty catheter. Denser areas of fibrosis were
treated by manipulating the inflated balloon of the
Fogarty catheter or removing them with a 1-mm flexible
endoscopic grasping forceps (Karl Storz GmbH, Tuttlin-
gen, Germany), if no blood vessels could be identified in
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the vicinity. The thickest and hardest fibrotic areas,
where the progression of the Fogarty and the endoscope
was not possible, usually corresponded to locations of a
complete block on the epidurogram (Figure 1). Thick
scar septa remaining after the use of the Fogarty
(Figure 2) were partially destroyed by a radiofrequency
catheter (Resaflex, MRT – Medical Device Manufac-
turer s.r.l., San PietroViminario, Padua, Italy), according
to the techniquedescribedbyRaffaeli andRighetti.44The
Resaflex is a disposable monopolar electrode, with a
plastic insulation of the shaft and an active ball tip with
0.8 mm diameter. It is used with a magnetic resonance
generator (Resablator 50, MRT – Medical Device
Manufacturer s.r.l., San Pietro Viminario, Padua, Italy)
with operating frequencies of 4, 8, 12, and 16 MHz,
allowing the transfer of energy capable of cauterizing and
coagulating the biological tissues without increasing the
tissue temperature above 50°C.
When a block was present on the initial epidurogram,
adhesiolysis was confirmed by a control injection of
nonionic contrast.
At the end of the procedure, 5 mL of bupivacaine
hydrochloride 0.5% and 12 mg of betamethasone
(betamethasone sodium phosphate 6 mg + betametha-
sone acetate 6 mg/2 mL, Celesdepot, Merck & Co.,
Inc., Whitehouse Station, NJ, U.S.A.) was injected in the
previously identified painful area. Then, the epiduro-
scope and the sleeve were removed and the skin entry
point was closed with a stitch using a resorbable surgical
thread and appropriate sterile dressing.
Postoperative Care
Patients stayed in a recovery room for 2 hours and were
then transferred to the neurosurgery ward postproce-
dure, with recommendations for monitoring of vital
signs, headache, neck and low back pain, neurological
symptoms, and surgical dressing. Immediate postoper-
ative analgesic regimen consisted of acetaminophen
1000 mg qid and diclofenac 50 mg tid.
Patients were kept in bed for at least 6 hours after the
procedure and were discharged the next morning. At
discharge, patients resumed their previous pain medica-
tion, with recommendation for dosage reduction
according to perceived pain decrease and improvement
in functional status.
Follow-Up and Outcomes Assessment
Visual analogue scale pain scores (back and lower limb)
were collected on the first day after the procedure (at
discharge). Then, patient-reported outcomes were col-
lected at predefined time intervals after the procedure:
2 weeks and 1; 3; 6; and 12 months. The outcome
parameters evaluated at these time intervals were VAS
pain score (back and lower limb); ODI; Stanford
score;61,62 and pain medication usage. The SF-36 Health
Survey scores were calculated at 6 and 12 months after
the procedure.
The Stanford score was developed to evaluate the
outcome of patients with lumbar radicular pain who
Figure 1. Epidurogram showing a complete block at the level of
L5 pedicles.
Figure 2. Epiduroscopic picture showing thick epidural fibrous
septa on the left side of the image.
70  PEREIRA ET AL.
underwent surgery and evaluates 4 parameters: intensity
of radicular pain; pain medication use; restriction of
activities; and satisfaction rating with the procedure and
its outcome. Each parameter is scored on a scale of 0 to
10, where higher values reflect better results. A total
score is then calculated as the mean of the scores on the 4
aforementioned scales.61,62
The primary objective was to evaluate changes
from baseline in VAS pain scores (back and lower
limb) over time up to 12 months. Secondary outcome
measures were the remaining above-mentioned out-
come instruments, as well as documentation of
adverse events.
Associated Treatments
Epiduroscopy was not repeated and no oral, intramus-
cular, or epidural steroids were prescribed during the
12-month follow-up period.
Nonsteroidal anti-inflammatory drugs and opioid
and nonopioid analgesics were used according to
patients’ needs.
Rehabilitation programs were maintained or resumed
after the procedure, as considered appropriate. No new
or specific co-interventions were offered during the
study follow-up.
Statistical Analysis
An a priori sample size calculation was not performed,
since the study protocol defined a time limit of
30 months for the enrollment of patients and we could
not estimate in advance how many patients would be
possible to include or the distribution of their pain
scores. For a sample of 24 individuals, with a power of
80% and a significance level of 0.05 we can detect with
this study a difference of 1.5 points, considered the
minimal important change, on the primary outcome
measures.63
Paired t-tests were performed to compare the baseline
with each assessment point. The P values and the
confidence intervals were adjusted using the Bonferroni
correction, assuming the number of comparisons per-
formed for each parameter. The observed (uncorrected)
P values were multiplied by the number of comparisons
made.
Mixed models, including random intercept, were
used to compare the pre- with the postintervention data
to assess the intervention effect and the time trends after
the intervention for the different outcome parameters.
The R statistical software version 2.15.1 (R Foundation,
Vienna, Austria) was used for data analysis and creation
of graphics. Box plots, the mean, and respective 95%
confidence intervals were estimated to describe each
outcome by time.
RESULTS
Patient Demographics and Baseline Data
A total of 24 patients were enrolled in this study.
Summary patient demographics are presented in
Table 1. In 10 patients (41.7%), the pain did not
improve after the lumbar discectomy, so they had
persistent symptoms. The remaining patients had pain-
free intervals after the surgery ranging from 2 months
to 13 years (mean: 51 months). Three patients under-
went additional surgical procedures (after discectomy
and before epiduroscopy), which did not result in
symptomatic relief (2 decompressions and 1 fusion
procedure). Six patients (25%) were working before
the procedure, 11 (45.8%) were on sick leave, and the
remaining were either retired or unemployed. All
patients, except 1 (who only had low back pain),
reported low back and lower limb pain. In 4 patients
(16.7%), the lower limb symptoms were bilateral.
Only 2 patients (8.3%) were not taking pain medica-
tion before the procedure and 11 patients (45.8%) had
Table 1. Patient Demographics and Clinical Features
Total number of patients 24
Gender
Male, n (%) 13 (54.2)
Female, n (%) 11 (45.8)
Age, mean  SD (years) 46.6  9.5
BMI, mean  SD (Kg/m2) 29.0  4.8
Duration of pain, mean  SD (months) 33.7  33.1
Time after previous surgery, mean  SD (months) 59.8  44.3
Pain-free interval after surgery, mean  SD (months) 29.7  42.8
Predominant pain, n (%)
Lower back 10 (41.7)
Lower limb 9 (37.5)
Both 5 (20.8)
VAS_back pain, mean  SD 6.9  2.1
VAS_lower limb pain, mean  SD 6.4  2.5
ODI, mean  SD (%) 43.8  13.3
Positive SLRT, n (%) 10 (41.7)
Motor radiculopathy, n (%) 6 (25.0)
Sensory radiculopathy, n (%) 10 (41.7)
DRAM, n (%)
Normal 5 (20.8)
At risk 11 (45.8)
Distressed somatic 4 (16.7)
Distressed depressive 4 (16.7)
SD, standard deviation; BMI, body mass index; SLRT, straight leg raising test VAS, visual
analogue scale; ODI, oswestry disability index; DRAM, distress and risk assessment
method.
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multidrug regimens for pain control. Opioids were
used by 5 patients (20.8%). Five patients (20.8%)
were taking antidepressants.
Procedural Data
The intervention data are illustrated in Table 2. The
procedure took between 40 and 100 minutes with a
mean of 57.7 minutes. The volume of saline solution
injected in the epidural space ranged from 120 to
650 mL (mean: 290.6 mL).
One-third of the patients had no block to the contrast
medium spread in the epidurogram. Only 1 of these
patients had predominant lower limb pain. In 9 patients,
there was an obstruction to the passage of contrast in the
central epidural space; this obstruction was complete in
5 cases and partial in the remaining. The level of the
blockage was L4–L5 in 3 patients, L5–S1 in 5, and both
levels in 1 patient. A block to the spread of contrast
around 1 nerve root was present in 6 patients (L5 in 4
and S1 in 2); 1 patient presented a block along L5 and S1
nerve roots on the same side. Among the 7 patients with
radicular blocks on the epidurogram, 5 (71.4%) had a
predominance of lower limb pain.
In all patients who presented filling defects on the
epidurogram, areas of fibrosis were found in corre-
sponding locations on direct endoscopic visualization.
Among patients with epidural block to the passage of
contrast, it was possible after adhesiolysis to progress
the endoscope cranially to that area in all patients but 1.
In such patient, it was possible to confirm the contrast
spreading cranially but not to progress the endoscope
after adhesiolysis. In most patients with periradicular
blocks, the results of the adhesiolysis were not so clearly
noticeable on the control epidurograms.
Overall, the Resaflex was used in 21 patients, the
biopsy forceps in 22, and the Fogarty in all cases.
It was possible to elicit the patient’s usual pain by
probing the vertebral canal structures with the tip of the
Fogarty in all patients. This painful area was consis-
tently at the site of previous surgery and epidural scar
tissue. The contents of the spinal canal (dura mater,
ligaments, nerve roots, blood vessels, epidural fat) in
other locations were not painful.
In 15 patients, samples of epidural scar tissue
obtained using a 1-mm flexible endoscopic grasping
forceps were processed for histological and immunohis-
tochemical analysis.64
Patient-Reported Outcomes
One patient reported no improvement at 1-month
follow-up and decided to withdraw from the study. All
other patients remained in the study and accomplished
the scheduled assessments up to 12 months after the
procedure.
The evolution of pain scores for the low back region
and lower limbs is depicted in Figures 3 and 4, respec-
tively, and Tables 3 and 4 show that there were
significant differences at each assessment point com-
pared with the baseline. After the procedure, low back
pain intensity decreased by 3.4 points (95% confidence
interval: 4.4 to 2.4, P < 0.0001) on the VAS, and
thereafter, it showed a tendency to increase by 0.3 points
for each 90-day period. Lower limb pain intensity
decreased by 3.8 points (95% confidence interval: 4.8
to 2.8, P < 0.0001) on the VAS, and thereafter, it
increased by 0.4 points for each 90-day period.
Table 2. Epiduroscopy Data
Number of patients 24
Duration, mean  SD (minutes) 57.7  12.9
Saline volume, mean  SD (mL) 290.6  133.8
Normal epidurogram, n (%) 8 (33.3)
Predominant back pain, n 3
Predominant lower limb pain, n 1
No pain predominance, n 4
Central block on epidurogram, n (%) 9 (37.5)
Predominant back pain, n 3
Predominant lower limb pain, n 2
No pain predominance, n 4
Radicular block on epidurogram, n (%) 7 (29.2)
Predominant back pain, n 2
Predominant lower limb pain, n 5
No pain predominance, n 0
SD, standard deviation.
Figure 3. Box plot representing VAS for low back pain at each
assessment point. Line segments connect the means for each
assessment point and the 95% confidence intervals are shown
with small T-bars.
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Functional outcome evaluated by the Oswestry Dis-
ability Index is presented in Figure 5 and Table 5. Two
weeks after the procedure, the ODI score (0–100 scale)
was reduced by 16.8 points (95% confidence interval:
7.4 to 26.3, P < 0.0001), and thereafter, it increased by
1.8 points for each 90-day period, according to the
mixed-effect model.
The overall outcome, using the Stanford score, is
shown in Figure 6 and Table 6. There were no signif-
icant differences for the total score on all assessment
points when compared with Day 15. Mean Stanford
score ranged from 6.8 to 7.6.
Table 4. Mean Differences on Visual Analogue Scale
(VAS) for Lower Limb Pain at Each Assessment Point
Compared to Baseline
Mean difference (95% CI) P value
Day 1 4.44 (2.56–6.31) < 0.001
Day 15 3.75 (1.78–5.71) < 0.001
Day 30 3.04 (1.32–4.77) < 0.001
Day 90 3.01 (1.23–4.79) < 0.001
Day 180 3.39 (1.51–5.26) < 0.001
Day 360 2.27 (0.38–4.16) 0.013
Confidence intervals (CI) and P values were adjusted using Bonferroni correction.
Table 5. Mean Differences on ODI at Each Assessment
Point Compared to Baseline
Mean difference (95% CI) P value
Day 15 16.84 (7.43 to 26.25) < 0.001
Day 30 11.28 (4.49 to 18.06) < 0.001
Day 90 8.02 (1.02 to 15.03) 0.019
Day 180 7.39 (0.06 to 14.83) 0.053
Day 360 6.74 (0.85 to 14.34) 0.101
Confidence intervals (CI) and P values were adjusted using Bonferroni correction.
Figure 4. Box plot representing Visual Analogue Scale (VAS) for lower limb pain at each assessment point. Line segments connect the
means for each assessment point and the 95% confidence intervals are shown with small T-bars.
Table 3. Mean Differences on Visual Analogue Scale
(VAS) for Low Back Pain at Each Assessment Point
Compared to Baseline
Mean difference (95% CI) P value
Day 1 4.42 (2.44–6.41) < 0.001
Day 15 2.78 (0.81–4.75) 0.003
Day 30 3.53 (1.66–5.40) < 0.001
Day 90 2.71 (0.62–4.81) 0.007
Day 180 2.38 (0.27–4.49) 0.021
Day 360 2.21 (0.07–4.35) 0.040
Confidence intervals (CI) and P values were adjusted using Bonferroni correction.
Figure 5. Box plot representing ODI score at each assessment
point. Line segments connect the means for each assessment
point and the 95% confidence intervals are shown with small T-
bars.
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Mean differences from baseline on each dimension of
the SF-36 Health Survey are presented in Table 7.
Statistically significant differences were found on the
dimensions of physical functioning and bodily pain at 6
and 12 months after the intervention compared to
baseline.
One month after the intervention, 50% of the
patients were not taking pain medications, compared
to 8.3% preoperatively. This rate dropped to 43.5%
at 3 months and 34.8% at 6 and 12 months. Only 2
patients (8.7%) were using opioids 12 months after
the procedure vs. 5 patients (20.8%) preoperatively.
One patient developed facet joint pain, distinct from
the pre-intervention pain, 6 months after the epiduros-
copy and underwent medial branch radiofrequency
neurotomy with pain relief. No other percutaneous
interventions were performed in any other patient.
Complications
Minor epidural bleeding was controlled with irrigation,
compression by the Fogarty or coagulation with the
radiofrequency catheter. There were no adverse events
or clinical consequences resulting from this bleeding.
One patient reported neck pain after irrigation of the
epidural space with a total volume of 200 mL of saline.
The pain resolved spontaneously and a slower infusion
rate allowed for the conclusion of the procedure. This
patient had no recurrence of the symptom or any
postoperative consequence.
Another patient presented with a S1 sensory deficit
following the procedure with full recovery within
48 hours.
No infection, additional neurological deficit, dural
tear, reaction to the instilled drugs, or any other
complication arouse from the procedure.
DISCUSSION
This study evaluated the results of lumbar endoscopic
adhesiolysis in a population of patients with failed back
surgery syndrome and symptomatic epidural fibrosis.
Statistically significant improvement in low back and
lower limb pain was reported in all assessment periods
up to 12 months, compared to baseline. Defining
clinically meaningful improvement as pain relief over
50%, as is advocated in a recent systematic review of the
topic by Helm et al.,31 a significant decrease in VAS pain
scores (back and/or lower limb) was found in 71% of the
patients at 1 month, 63% at 3 and 6 months, and 38%
at 12 months. These results are in line, although
somewhat lower, with those reported by Manchikanti
et al.,34 who presented significant pain relief in 90% of
the patients at 1 month, 80% at 3 months, 56% at
6 months, and 48% at 12 months. However, it should
be noted that 16% of their patients did not have a
history of previous surgery. Moreover, baseline data
were used at 3-, 6-, and 12-month assessments in 2
Table 6. Mean Differences on Stanford Score at Each
Assessment Point Compared to Day 15
Mean (SD) Mean difference (95% CI) P value
Day 15 7.5 (1.7) Ref
Day 30 7.6 (1.9) 0.14 (1.09; 0.80) 1.000
Day 90 7.4 (1.9) 0.10 (0.97; 1.17) 1.000
Day 180 7.1 (2.2) 0.45 (0.69; 1.59) 1.000
Day 360 6.8 (2.4) 0.60 (0.95; 2.16) 1.000
Confidence intervals (CI) and P values were adjusted using Bonferroni correction.
Figure 6. Box plot representing total Stanford score at each
assessment point. Line segments connect the means for each
assessment point and the 95% confidence intervals are shown
with small T-bars.
Table 7. Mean Differences on Each Dimension of SF-36 at
6 and 12 months Compared to Baseline
Dimension
6-month mean
difference (95% CI)
12-month mean difference
(95% CI)
Physical functioning 14.44 (3.83; 25.06)* 18.83 (2.29; 35.37)*
Role-physical 11.11 (44.00; 66.22) 22.91 (23.24; 69.07)
Bodily pain 24.56 (7.38; 41.72)* 13.17 (1.38; 24.95)*
General health 5.78 (19.08; 7.53) 3.50 (27.90; 20.95)
Vitality 9.22 (13.81; 32.25) 8.00 (13.22; 29.22)
Social functioning 16.78 (27.01; 60.56) 6.00 (27.25; 39.25)
Role-emotional 33.22 (22.17; 88.61) 47.25 (6.75; 87.78)*
Mental health 15.56 (1.67; 32.78) 12.5 (1.82; 26.82)
Confidence intervals (CI) and P values were adjusted using Bonferroni correction.
*Represents a P value <0.05.
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patients, 3-month data at 6- and 12-month analyses in 6
patients, and 6-month data at 12-month analysis in 8
patients, which could have some influence in the results.
Lastly, pain medication affects VAS scores. At
12 months, 40% of their patients had significant opioid
intake vs. 8.7% in our group.
A previous retrospective study by Manchikanti
et al.,47 including only patients with failed back surgery
syndrome, reported lower rates of significant pain relief
(97% at 1 month, 52% at 3 months, 22% at 6 months,
and 8% at 12 months). Either in such study or in
another by Di Donato et al.,38 all patients experienced
significant pain relief after the procedure. On the
contrary, in our study, 4 patients (16.7%) did not
achieve a pain relief > 50% on the first day after the
intervention. Interestingly, 2 of these patients had a
significant pain relief 2 weeks later, lasting for 3 months
in 1 patient and 12 months in the other. The remaining
2 patients failed to achieve significant pain relief over the
entire follow-up and were considered treatment failures.
After reviewing clinical data and procedural findings, it
was not possible to identify predictive features of this
type of response.
Pain relief was reflected in an improvement in
functional status assessed by the ODI, as in previous
studies on the same topic.34,35,38 The impact of this
improvement was less evident on SF-36 Health Survey.
Even so, the scores on the physical functioning, bodily
pain, and role-emotional dimensions were significantly
higher 12 months after the procedure compared to
baseline. Furthermore, the mental health dimension also
showed a trend toward improvement. The reduction in
pain intensity and disability translated into high levels of
patient satisfaction with the outcome of the interven-
tion, decreased use of analgesics and high rates on the
Stanford score. Mean patient satisfaction rates were
80% at 1 month, 75% at 3 months, 70% at 6 months,
and 67% 1 year after the intervention.
Direct comparisons of these results to other publica-
tions on spinal endoscopy are not easy, because of the
heterogeneity of inclusion criteria and the use of distinct
surgical techniques and uneven instruments and criteria
for outcome assessment. Raffaeli et al.18 reported the
largest series of epiduroscopy in the literature, including
662 patients, 304 of whom with FBSS. They state that
59% of the FBSS patients were improved 1 year after the
procedure and 56% of the overall group showed a pain
reduction over 50%. However, this result is not based
on a scale, but rather on a statement of the patient
during a telephone interview of a pain relief above or
below 50%. Di Donato et al.38 reported a series of 350
patients who underwent epiduroscopy, with the longest
follow-up in the literature (60 months). However,
selection criteria were very broad, including patients
with FBSS, spondylolisthesis, stenosis, and disk hernia-
tion. Moreover, all patients had refused surgical lumbar
fusion, which is not a standard procedure for some of
these diagnoses. In their study, a pain VAS < 5 and a
score on ODI < 40% were considered a good outcome,
yet 60% of the patients presented an ODI score < 40%
at baseline. Murai et al.,48 on behalf of the Japan
Society of Epiduroscopy, reported a multi-institutional
study including 183 patients from 15 centers. Of those,
37 had a previous lumbar decompression surgery.
Although the outcome scores were not presented in
numbers, but displayed in graphs, the authors report
significantly better scores for pain and function at
3 months compared to baseline.
Several publications on epiduroscopy exclude patients
with FBSS or include a number of less than 20 patients
with this diagnosis,14,36,37,39,41–43,46,65–70 whereas a
paper by Ruetten et al.40 included 93 patients, 21 of
whom with previous disk surgery, but presented only 8-
week follow-up for the overall population.
Takeshima et al.35 examined the impact of the loca-
tion of the epidural fibrosis, assessed by an epidurogram
performed 2 weeks before the procedure and hence the
place where the adhesiolysis was performed, on the
treatment results. They concluded that the improvement
lasted longer among patients with radicular pain in
whom the adhesiolysis was performed around the nerve
root. Although we did not specifically address this
question, in our patients with predominant lower limb
pain, themean duration of significant pain relief (> 50%)
after the procedure was 24.5 weeks vs. 22.8 weeks
among patients with predominant low back pain.
Bosscher and Heavner evaluated the significance of
epiduroscopic findings in predicting the outcome of the
treatment, suggesting that information obtained
through epiduroscopy may carry significant diagnostic
and prognostic value.37 However, only 12 patients
(8.6%) of their study population had previous spine
surgery, and therefore, these results cannot reliably be
extrapolated to patients with FBSS. Furthermore, the
major predictor of outcome considered in the above-
mentioned paper was the patency of the neuroforamen,
which is a relevant diagnostic parameter for patients
with radicular pain. Patients included in the present
study, as a large proportion of FBSS cases, had a
combination of low back and lower limb pain and
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multiple components were likely involved, including
nociceptive, radicular, somatic referred, and neuropath-
ic.3,71–74
Most publications on epiduroscopy recommend lim-
iting the volume of saline solution injected into the
epidural space at a maximum between 100 and 350 mL
to avoid complications related to increased hydrostatic
pressure in this compartment.18,34,38,43,45 We have used
volumes up to 650 mL with no complications during or
after the procedure. We advocate not using a valve in the
irrigation portal of the endoscope and injecting the
saline in small boluses. This way, the hydrostatic
pressure in the epidural space is kept within safe limits
and a good endoscopic visualization is achieved. Most of
the injected volume flows back through the portals of
the endoscope and likely will also exit the epidural space
through the intervertebral foramina. Another theoretical
benefit of using higher volumes of saline could be to
improve the washout of phospholipase A2 and pro-
inflammatory cytokines, namely tumor necrosis factor-a
and interleukins IL-1b, IL-6, and IL-8 from the epidural
space.14,36
In every patient, the usual pain could be triggered by
stimulation with the tip of the Fogarty in the region of
prior surgery. This identification of the pain generator
replicates the results reported by Richardson et al.14 and
demonstrates the value of epiduroscopy as a diagnostic
tool in patients with FBSS and as a therapeutic proce-
dure, enabling a very accurate application of drugs in the
most painful areas.
The only postoperative adverse effect in the present
series was 1 case of a transient radicular sensory distur-
bance, with a full recovery within 48 hours, thus con-
firming spinal endoscopic adhesiolysis as a safe procedure
when performed according to strict criteria and using a
meticulous technique. This result is in line with a recent
systematic review on the topic, where the authors
conclude that the procedure is generally well tolerated,
with infrequent, minimal, and transient complications,31
although rare but significant adverse events have been
described, including visual impairment,75 neurogenic
bladder,76 encephalopathy,77 meningitis,39 seizures,45
radiculopathy,39,42 and intradural cyst formation.78
The main strength of this study is the inclusion of
a quite homogeneous group of patients, all of them
with previous lumbar spine surgery, in whom specific
diagnoses such as disk herniation, stenosis, or insta-
bility have been excluded. The procedural technique
was very consistent throughout the series. Moreover,
patient-reported outcome data were prospectively
collected in protocol-defined times along 12 months,
with a high follow-up rate of 96% at the final
assessment, and the results are robust and statistically
significant.
As in other case series, this study does not control
for the possibility of placebo effect and natural
improvement. Yet the latter is unlikely, given the
mean duration of symptoms of about 3 years and the
failure of improvement along this period despite
multiple treatments. The inclusion of a control group
did not seem to us appropriate or easy to design. On
one hand, a sham intervention would be difficult to
simulate, not to mention the associated costs, and
there would be ethical issues regarding performing an
invasive sham procedure. Besides, the purpose of this
study was to address the results of a procedure that
includes multiple therapeutic interventions (adminis-
tration of epidural steroids, washout of inflammatory
mediators, adhesiolysis) and not the contribution of
each one of them to the outcome, which would require
a cohort distribution. Lastly, the willingness and
availability of patients to participate in a randomized
trial is reduced, at least in the social and cultural
environment in which the study was conducted.
In conclusion, this study supports the role of endo-
scopic adhesiolysis for the relief of chronic intractable
low back and lower limb pain in patients with previous
lumbar spine surgery, when a specific diagnosis for the
cause for the symptoms is not possible to achieve. The
use of large volumes of saline during endoscopy and the
employment of radiofrequency for the lysis of epidural
adhesions, according to the technique described, may
bring an additional benefit to the procedure.
The number of patients included in this series does
not allow a proper subgroup analysis. Further investi-
gation with a larger number of patients and variable
analysis may throw light on predicting which patients
are more likely to improve with the procedure.
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